Patents by Inventor Charles E. Pendley, II

Charles E. Pendley, II has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rapidly absorbed liquid compositions
    Patent number: 7060730
    Abstract: The present invention provides a method which provides for a faster absorption of pharmaceutically acceptable amines. The method provides a pharmaceutically acceptable amine in combination with a non-steroidal anti-inflammatory drug in a liquid form. A preferred embodiment employs pseudoephedrine and ibuprofen.
    Type: Grant
    Filed: June 26, 2003
    Date of Patent: June 13, 2006
    Inventors: Cathy Klech Gelotte, Joanna F. Hills, Charles E. Pendley, II, Manoj N. Shah
  • Rapidly absorbed liquid compositions
    Patent number: 6211246
    Abstract: The present invention provides a method which provides for a faster absorption of pharmaceutically acceptable amines. The method provides a pharmaceutically acceptable amine in combination with a non-steroidal anti-inflammatory drug in a liquid form. A preferred embodiment employs pseudoephedrine and ibuprofen.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: April 3, 2001
    Assignee: McNeil-PPC, Inc.
    Inventors: Cathy Klech Gelotte, Joanna F. Hills, Charles E. Pendley, II, Manoj N. Shah
  • Treatment of conditions requiring enhanced oxygen availability of mammalian tissues
    Patent number: 5015663
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: March 5, 1990
    Date of Patent: May 14, 1991
    Assignee: Rhone-Poulenc Rorer Pharmaceuticals Inc.
    Inventors: John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4948582
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: May 11, 1989
    Date of Patent: August 14, 1990
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4861795
    Abstract: Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
    Type: Grant
    Filed: June 23, 1988
    Date of Patent: August 29, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: John T. Suh, Robert G. Pendelton, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber
  • Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
    Patent number: 4849416
    Abstract: Disclosed are pharmaceutical compositions containing certain heterocylcic sulphonamido azo compounds for enhancing oxygen availability to mammalian tissue.
    Type: Grant
    Filed: July 25, 1988
    Date of Patent: July 18, 1989
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Robert G. Pendleton, Charles E. Pendley, II, John T. Suh, Kin T. Yu, Paul R. Menard, Tihamer Herczeg